title: FK 506: monitoring in plasma or in whole blood?
authors.affiliation: Department of Clinical Pharmacy, University Hospital Maatricht, The Netherlands.
authors.forename: A J
authors.initials: AJ
authors.lastname: Beysens
authors.forename: R M
authors.initials: RM
authors.lastname: Wijnen
authors.forename: G H
authors.initials: GH
authors.lastname: Beuman
authors.forename: J
authors.initials: J
authors.lastname: van der Heyden
authors.forename: G
authors.initials: G
authors.lastname: Kootstra
authors.forename: H
authors.initials: H
authors.lastname: van As
mesh_terms: D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods; D004797:Enzyme-Linked Immunosorbent Assay; D006400:Hematocrit; D006801:Humans; D010949:Plasma / Q000737:chemistry; D016559:Tacrolimus / Q000097:blood*; D013696:Temperature
chemical_list: D016559:Tacrolimus